Ls. Szczepaniak et al., Measurement of intracellular triglyceride stores by H-1 spectroscopy: validation in vivo, AM J P-ENDO, 39(5), 1999, pp. E977-E989
Citations number
71
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
We validate the use of H-1 magnetic resonance spectroscopy (MRS) to quantit
atively differentiate between adipocyte and intracellular triglyceride (TG)
stores by monitoring the TG methylene proton signals at 1.6 and 1.4 ppm, r
espectively. In two animal models of intracellular TG accumulation, intrahe
patic and intramyocellular TG accumulation was confirmed histologically. Co
nsistent with the histological changes, the methylene signal intensity at 1
.4 ppm increased in both liver and muscle, whereas the signal at 1.6 ppm wa
s unchanged. In response to induced fat accumulation, the TG concentration
in liver derived from H-1 MRS increased from 0 to 44.9 +/- 13.2 mu mol/g, a
nd this was matched by increases measured biochemically(2.1 +/- 1.1 to 46.1
+/- 10.9 mu mol/g). Supportive evidence that the methylene signal at 1.6 p
pm in muscle is derived from investing interfascial adipose tissue was the
finding that, in four subjects with generalized lipodystrophy, a disease ch
aracterized by absence of interfacial fat, no signal was detected at 1.6 pp
m; however, a strong signal was seen at 1.4 ppm. An identical methylene che
mical shift at 1.4 ppm was obtained in human subjects with fatty liver wher
e the fat is located exclusively within hepatocytes. In experimental animal
s, there was a close correlation between hepatic TG content measured in viv
o by H-1 MRS and chemically by liver biopsy [R = 0.934; P < .0001; slope 0.
98, confidence interval(CI) 0.70-1.17; gamma-intercept 0.26, CI -0.28 to 0.
70]. When applied to human calf muscle, the coefficient of variation of the
technique in measuring intramyocellular TG content was 11.8% in nonobese s
ubjects and 7.9% in obese subjects and of extramyocellular (adipocyte) fat
was 22.6 and 52.5%, respectively. This study demonstrates for the first tim
e that noninvasive in vivo H-1 MRS measurement of intracellular TG, includi
ng that within myocytes, is feasible at 1.5-T field strengths and is compar
able in accuracy to biochemical measurement. In addition, in mixed tissue s
uch as muscle, the method is clearly advantageous in differentiating betwee
n TG from contaminating adipose tissue compared with intramyocellular lipid
s.